02373 BEAUTYFARM MED
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.98X | Oper Margin | 16.1% |
|---|---|---|---|
| LT Debt/Equity | 97.4% | Net Margin | 10.6% |
| Total Debt/Equity | 126.7% | Return on Equity | 31.1% |
| Price/Book | 4.03X | Return on Assets | 6.3% |
| (HKD 19.500) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 353.48 | 242.97 | 237.70 | 115.61 | 236.64 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +45.5 | +2.2 | +105.6 | -51.2 | +32.1 |
| Earnings Per Share (HKD) | 1.541 | 1.058 | 1.04 | 0.578 | 1.184 |
| Earnings Per Share Growth (%) | +45.6 | +1.8 | +79.8 | -51.1 | -34.1 |
| Dividend Per Share (HKD) | 0.720 | 0.520 | 0.470 | 0.390 | No dividend |
| P/E* (X) | 12.66 | 18.43 | 18.75 | 33.72 | 16.47 |
| Yield (%) | 3.69 | 2.67 | 2.41 | 2.00 | N/A |
| Dividend Share (%) | 46.74 | 49.14 | 45.20 | 67.44 | N/A |
| Book NAV (HKD) | 4.844 | 4.261 | 3.739 | 0.918 | N/A |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 3,001 | 2,572 | +16.7 | 2,145 |
| Operating Result | 464.03 | 324.959 | +42.8 | 289.328 |
| Associates | 0 | 0 | N/A | -0.051 |
| Profit Before Taxation | 450.066 | 317.883 | +41.6 | 288.269 |
| Taxation | 109.791 | 65.405 | +67.9 | 58.13 |
| Profit /( Loss) After Taxation | 340.275 | 252.478 | +34.8 | 230.139 |
| Minority Interests | 22.713 | 24.018 | -5.4 | 14.482 |
| Net Profit | 317.562 | 228.46 | +39.0 | 215.657 |
| Earnings Per Share () | 1.5406 | 1.0582 | +45.6 | 1.0399 |
| Dividend Per Share () | 0.7200 | 0.5200 | +38.5 | 0.4700 |
| Announcement Date | 2026-03-27 | 2025-03-26 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
